Prevnar 13
Links shared publicly online about this topic
Prevnar 13 Drug Interactions
kids.emedtv.com — “Warfarin and heparin are two of the drugs that can potentially interact with Prevnar 13. This eMedTV resource looks at other medications that can interfere with the vaccine, with information on the problems that may occur as a result.” View full resource at kids.emedtv.com
Most Recently Shared on September 30, 2010 at 9:09 pm By:
Just added http://bit.ly/cy9yTX to the Prevnar 13 Drug Interactions WisdomCard http://bit.ly/b9xwUk @organizedwisdom
Prevnar 13 Dosage
kids.emedtv.com — “As explained in this eMedTV segment, Prevnar 13 is given as one to four doses, depending on the age when the first dose is given. This page takes an in-depth look at the dosing schedule for this vaccine, with information on how it is typically injected.” View full resource at kids.emedtv.com
Most Recently Shared on September 30, 2010 at 9:09 pm By:
Just added http://bit.ly/9oguIw to the Prevnar 13 Dosage WisdomCard http://bit.ly/94soZd @organizedwisdom
Generic Prevnar 13
kids.emedtv.com — “As explained in this selection from the eMedTV Web site, there are no generic versions of Prevnar 13 (pneumococcal conjugate vaccine) available at this time. This article explains why this is so and explores the rules surrounding "biologic" drugs.” View full resource at kids.emedtv.com
Most Recently Shared on September 30, 2010 at 8:38 pm By:
Just added http://bit.ly/aierly to the Generic Prevnar 13 WisdomCard http://bit.ly/dmAnlE @organizedwisdom
Pfizer provides update on Prevnar 13
news-medical.net — “Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has not yet completed its review of the Biologics License Application (BLA) for Prevnar 13", (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's candidate 13-valent pneumococcal conjugate vaccine.” View full resource at news-medical.net
Most Recently Shared on December 31, 2009 at 5:45 am By:
Pfizer provides update on Prevnar 13: Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) ... http://bit.ly/7DuXdf
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine
drugs.com — “Prevnar 13 (pneumococcal 13-valent conjugate vaccine) is used for prophylaxis of pneumococcal disease. Includes Prevnar 13 side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 26, 2010 at 1:03 am By:
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine - http://bit.ly/cx9k4D
Prevnar 13 Vaccine For Pneumococcal Disease For Adults Meets All Endpoints
medicalnewstoday.com — “Prevnar 13, a pneumonia vaccine, was found effective for patients aged 50+ in two clinical trials as its maker, Pfizer, applies to expand the vaccine's use. Pfizer says the vaccine met all study e” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2011 at 7:05 am By:
Prevnar 13 Vaccine For Pneumococcal Disease For Adults Meets All Endpoints http://mnt.to/3VBH #healthnews
FDA approves Prevnar 13; ACIP issues recommendations for use
pediatricsupersite.com — “The FDA today approved Pfizer’s Prevnar 13, indicated for the active immunization of children to prevent invasive disease caused by Strepto” View full resource at pediatricsupersite.com
Most Recently Shared on February 24, 2010 at 8:35 pm By:
Pediatric SuperSite Health Site
FDA approves Prevnar 13; ACIP issues recommendations for use: http://ow.ly/1aVtz
Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease
news-medical.net — “Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacterem” View full resource at news-medical.net
Most Recently Shared on December 24, 2009 at 2:02 am By:
Meningitis News: Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease: Following a Priority ... http://bit.ly/58SP9P
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)
theannals.com — “Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)” View full resource at theannals.com
Most Recently Shared on November 2, 2011 at 3:45 am By:
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December): OBJECTIVE:To review the immunogenicity,... http://t.co/UCOTnIgs
Pfizer sees big Prevnar 13 sales among adults | Reuters
reuters.com — “*Could generate peak sales of $1.5 billion annually NEW YORK, Jan 12 (Reuters) - Pfizer Inc on Tuesdaysaid it plans to seek approvals this year for use of itsexperimental Prevnar 13 vaccine” View full resource at reuters.com
Most Recently Shared on January 12, 2010 at 7:55 pm By:
Pfizer sees big Prevnar 13 sales among adults. http://is.gd/696E7
Pfizer receives FDA approval for Prevnar 13 vaccine - FirstWord
firstwordplus.com — “Pfizer receives FDA approval for Prevnar 13 vaccine - FirstWord” View full resource at firstwordplus.com
Most Recently Shared on February 24, 2010 at 4:17 pm By:
RT @fwpharma: FDA approves Pfizer's Prevnar 13. http://bit.ly/b2w6VF
NYT: F.D.A. Approves Prevnar 13 Vac
mobile.nytimes.com — “The vaccine, Prevnar 13, is effective against more types of bacteria, particularly a virulent subtype called strain 19A.” View full resource at mobile.nytimes.com
Most Recently Shared on February 24, 2010 at 7:52 pm By:
F.D.A. Approves Prevnar 13 Vaccine for Child Infections http://j.mp/cLsa0h
Phase 3 Studies of Prevnar 13 for Pneumococcal Vaccination in Older Adults - ONA
oncologynurseadvisor.com — “Pfizer Inc announced results from two Phase 3 studies of Prevnar 13 (Pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) for vaccination in adults 50 years.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 9, 2011 at 7:29 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Studies of Prevnar 13 for Pneumococcal Vaccination in Older Adults http://goo.gl/fb/75RVH
Phase 3 Studies of Prevnar 13 for Pneumococcal Vaccination - MPR
empr.com — “Pfizer Inc announced results from two Phase 3 studies of Prevnar 13 (Pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) for vaccination in adults 50 years.” View full resource at empr.com
Most Recently Shared on May 9, 2011 at 2:57 pm By:
MPR News: Phase 3 Studies of Prevnar 13 for Pneumococcal Vaccination: Pfizer Inc announced results from two Phas... http://bit.ly/iIfHg4
Phase 3 Studies of Prevnar 13 for Pneumococcal Vaccination in Older Adults - MPR
empr.com — “Pfizer Inc announced results from two Phase 3 studies of Prevnar 13 (Pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) for vaccination in adults 50 years.” View full resource at empr.com
Most Recently Shared on May 9, 2011 at 7:30 pm By:
MPR News: Phase 3 Studies of Prevnar 13 for Pneumococcal Vaccination in Older Adults: Pfizer Inc announced resul... http://bit.ly/iMHFNI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
Catherine K
Work in health publishing field. Passionate about healthy living.
Advertisement
